EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
The European Commission (EC) has granted expanded approval to Bristol Myers Squibb’s (BMS) cluster of differentiation 19 ...
GEN - Genetic Engineering and Biotechnology News18h
StockWatch: Will BMS–2seventy Deal Prove a Win-Win?
Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...
The Pharma Letter23h
The week in pharma: action, reaction and insight – week to March 14
The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...